Amedisys (AMED) Tops Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Amedisys Reports Second Quarter Financial Results
July 29, 2015 7:00 AM EDTBATON ROUGE, La., July 29, 2015 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED), a leading home health and hospice company, today reported its financial results for the three and six-month periods ended June 30, 2015.
Three-Month Periods Ended June 30, 2015 and 2014
After adjusting for the 2015 period, $6.4 million ($3.9 million, net of income tax) or $0.12 per diluted share and for the 2014 period $0.8 million ($0.5 million, net of income tax) or $0.02 per diluted share for certain items*, our adjusted results from continuing operations were as follows:... More


